Lapatinib plus paclitaxel as first-line therapy for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: inappropriate conclusions from a company-sponsored study?

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
• Breast Neoplasms / drug therapy*
• Breast Neoplasms / genetics
• Breast Neoplasms / secondary
• Female
• Genes, erbB-2
• Humans
• Lapatinib
• Paclitaxel / administration & dosage
• Quinazolines / administration & dosage